Global Hereditary Cancer Testing Market Insights, Forecast to 2031

Report ID: 1667040 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 RNA Testing
        1.2.3 DNA Testing
    1.3 Market by Application
        1.3.1 Global Hereditary Cancer Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Breast Cancer
        1.3.3 Gastrointestinal Cancer
        1.3.4 Prostate Cancer
        1.3.5 Respiratory/Lung Cancer
        1.3.6 Other Cancers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hereditary Cancer Testing Market Perspective (2017-2028)
    2.2 Hereditary Cancer Testing Growth Trends by Region
        2.2.1 Hereditary Cancer Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hereditary Cancer Testing Historic Market Size by Region (2017-2022)
        2.2.3 Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028)
    2.3 Hereditary Cancer Testing Market Dynamics
        2.3.1 Hereditary Cancer Testing Industry Trends
        2.3.2 Hereditary Cancer Testing Market Drivers
        2.3.3 Hereditary Cancer Testing Market Challenges
        2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Cancer Testing Players by Revenue
        3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2017-2022)
        3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
    3.4 Global Hereditary Cancer Testing Market Concentration Ratio
        3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2021
    3.5 Hereditary Cancer Testing Key Players Head office and Area Served
    3.6 Key Players Hereditary Cancer Testing Product Solution and Service
    3.7 Date of Enter into Hereditary Cancer Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
    4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2017-2022)
    4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028)
5 Hereditary Cancer Testing Breakdown Data by Application
    5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2017-2022)
    5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hereditary Cancer Testing Market Size (2017-2028)
    6.2 North America Hereditary Cancer Testing Market Size by Type
        6.2.1 North America Hereditary Cancer Testing Market Size by Type (2017-2022)
        6.2.2 North America Hereditary Cancer Testing Market Size by Type (2023-2028)
        6.2.3 North America Hereditary Cancer Testing Market Share by Type (2017-2028)
    6.3 North America Hereditary Cancer Testing Market Size by Application
        6.3.1 North America Hereditary Cancer Testing Market Size by Application (2017-2022)
        6.3.2 North America Hereditary Cancer Testing Market Size by Application (2023-2028)
        6.3.3 North America Hereditary Cancer Testing Market Share by Application (2017-2028)
    6.4 North America Hereditary Cancer Testing Market Size by Country
        6.4.1 North America Hereditary Cancer Testing Market Size by Country (2017-2022)
        6.4.2 North America Hereditary Cancer Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Hereditary Cancer Testing Market Size (2017-2028)
    7.2 Europe Hereditary Cancer Testing Market Size by Type
        7.2.1 Europe Hereditary Cancer Testing Market Size by Type (2017-2022)
        7.2.2 Europe Hereditary Cancer Testing Market Size by Type (2023-2028)
        7.2.3 Europe Hereditary Cancer Testing Market Share by Type (2017-2028)
    7.3 Europe Hereditary Cancer Testing Market Size by Application
        7.3.1 Europe Hereditary Cancer Testing Market Size by Application (2017-2022)
        7.3.2 Europe Hereditary Cancer Testing Market Size by Application (2023-2028)
        7.3.3 Europe Hereditary Cancer Testing Market Share by Application (2017-2028)
    7.4 Europe Hereditary Cancer Testing Market Size by Country
        7.4.1 Europe Hereditary Cancer Testing Market Size by Country (2017-2022)
        7.4.2 Europe Hereditary Cancer Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2017-2028)
    8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type
        8.2.1 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Hereditary Cancer Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Application
        8.3.1 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Hereditary Cancer Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Hereditary Cancer Testing Market Size by Region
        8.4.1 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Hereditary Cancer Testing Market Size (2017-2028)
    9.2 Latin America Hereditary Cancer Testing Market Size by Type
        9.2.1 Latin America Hereditary Cancer Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Hereditary Cancer Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Hereditary Cancer Testing Market Share by Type (2017-2028)
    9.3 Latin America Hereditary Cancer Testing Market Size by Application
        9.3.1 Latin America Hereditary Cancer Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Hereditary Cancer Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Hereditary Cancer Testing Market Share by Application (2017-2028)
    9.4 Latin America Hereditary Cancer Testing Market Size by Country
        9.4.1 Latin America Hereditary Cancer Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Hereditary Cancer Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2017-2028)
    10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type
        10.2.1 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Hereditary Cancer Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Application
        10.3.1 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Hereditary Cancer Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Hereditary Cancer Testing Market Size by Country
        10.4.1 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Ambry Genetics (Konica Minota)
        11.1.1 Ambry Genetics (Konica Minota) Company Details
        11.1.2 Ambry Genetics (Konica Minota) Business Overview
        11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
        11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.1.5 Ambry Genetics (Konica Minota) Recent Developments
    11.2 Asper Biogene
        11.2.1 Asper Biogene Company Details
        11.2.2 Asper Biogene Business Overview
        11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
        11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.2.5 Asper Biogene Recent Developments
    11.3 Natera
        11.3.1 Natera Company Details
        11.3.2 Natera Business Overview
        11.3.3 Natera Hereditary Cancer Testing Introduction
        11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.3.5 Natera Recent Developments
    11.4 Caris Life Sciences
        11.4.1 Caris Life Sciences Company Details
        11.4.2 Caris Life Sciences Business Overview
        11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
        11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.4.5 Caris Life Sciences Recent Developments
    11.5 BioReference Laboratories (GeneDx)
        11.5.1 BioReference Laboratories (GeneDx) Company Details
        11.5.2 BioReference Laboratories (GeneDx) Business Overview
        11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
        11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.5.5 BioReference Laboratories (GeneDx) Recent Developments
    11.6 LabSolutions
        11.6.1 LabSolutions Company Details
        11.6.2 LabSolutions Business Overview
        11.6.3 LabSolutions Hereditary Cancer Testing Introduction
        11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.6.5 LabSolutions Recent Developments
    11.7 Progenity，Inc
        11.7.1 Progenity，Inc Company Details
        11.7.2 Progenity，Inc Business Overview
        11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
        11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.7.5 Progenity，Inc Recent Developments
    11.8 ARUP Laboratories
        11.8.1 ARUP Laboratories Company Details
        11.8.2 ARUP Laboratories Business Overview
        11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
        11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.8.5 ARUP Laboratories Recent Developments
    11.9 Myriad
        11.9.1 Myriad Company Details
        11.9.2 Myriad Business Overview
        11.9.3 Myriad Hereditary Cancer Testing Introduction
        11.9.4 Myriad Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.9.5 Myriad Recent Developments
    11.10 NeoGenomics
        11.10.1 NeoGenomics Company Details
        11.10.2 NeoGenomics Business Overview
        11.10.3 NeoGenomics Hereditary Cancer Testing Introduction
        11.10.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.10.5 NeoGenomics Recent Developments
    11.11 Blueprint Genetics
        11.11.1 Blueprint Genetics Company Details
        11.11.2 Blueprint Genetics Business Overview
        11.11.3 Blueprint Genetics Hereditary Cancer Testing Introduction
        11.11.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.11.5 Blueprint Genetics Recent Developments
    11.12 CellMax Life
        11.12.1 CellMax Life Company Details
        11.12.2 CellMax Life Business Overview
        11.12.3 CellMax Life Hereditary Cancer Testing Introduction
        11.12.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.12.5 CellMax Life Recent Developments
    11.13 Fulgent Genetics
        11.13.1 Fulgent Genetics Company Details
        11.13.2 Fulgent Genetics Business Overview
        11.13.3 Fulgent Genetics Hereditary Cancer Testing Introduction
        11.13.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.13.5 Fulgent Genetics Recent Developments
    11.14 Strand Life Sciences
        11.14.1 Strand Life Sciences Company Details
        11.14.2 Strand Life Sciences Business Overview
        11.14.3 Strand Life Sciences Hereditary Cancer Testing Introduction
        11.14.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.14.5 Strand Life Sciences Recent Developments
    11.15 Myogenes
        11.15.1 Myogenes Company Details
        11.15.2 Myogenes Business Overview
        11.15.3 Myogenes Hereditary Cancer Testing Introduction
        11.15.4 Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.15.5 Myogenes Recent Developments
    11.16 LabCorp
        11.16.1 LabCorp Company Details
        11.16.2 LabCorp Business Overview
        11.16.3 LabCorp Hereditary Cancer Testing Introduction
        11.16.4 LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.16.5 LabCorp Recent Developments
    11.17 Quest Diagnostics
        11.17.1 Quest Diagnostics Company Details
        11.17.2 Quest Diagnostics Business Overview
        11.17.3 Quest Diagnostics Hereditary Cancer Testing Introduction
        11.17.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.17.5 Quest Diagnostics Recent Developments
    11.18 Pathway Genomics
        11.18.1 Pathway Genomics Company Details
        11.18.2 Pathway Genomics Business Overview
        11.18.3 Pathway Genomics Hereditary Cancer Testing Introduction
        11.18.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022)
        11.18.5 Pathway Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of RNA Testing
    Table 3. Key Players of DNA Testing
    Table 4. Global Hereditary Cancer Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Hereditary Cancer Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Hereditary Cancer Testing Market Share by Region (2017-2022)
    Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Hereditary Cancer Testing Market Share by Region (2023-2028)
    Table 10. Hereditary Cancer Testing Market Trends
    Table 11. Hereditary Cancer Testing Market Drivers
    Table 12. Hereditary Cancer Testing Market Challenges
    Table 13. Hereditary Cancer Testing Market Restraints
    Table 14. Global Hereditary Cancer Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Hereditary Cancer Testing Revenue Share by Players (2017-2022)
    Table 16. Global Top Hereditary Cancer Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
    Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
    Table 21. Date of Enter into Hereditary Cancer Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Hereditary Cancer Testing Revenue Share by Application (2017-2022)
    Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Hereditary Cancer Testing Revenue Share by Application (2023-2028)
    Table 31. North America Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Hereditary Cancer Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Hereditary Cancer Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Hereditary Cancer Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Hereditary Cancer Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Hereditary Cancer Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Hereditary Cancer Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Hereditary Cancer Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Hereditary Cancer Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Ambry Genetics (Konica Minota) Company Details
    Table 62. Ambry Genetics (Konica Minota) Business Overview
    Table 63. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
    Table 64. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 65. Ambry Genetics (Konica Minota) Recent Developments
    Table 66. Asper Biogene Company Details
    Table 67. Asper Biogene Business Overview
    Table 68. Asper Biogene Hereditary Cancer Testing Product
    Table 69. Asper Biogene Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 70. Asper Biogene Recent Developments
    Table 71. Natera Company Details
    Table 72. Natera Business Overview
    Table 73. Natera Hereditary Cancer Testing Product
    Table 74. Natera Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 75. Natera Recent Developments
    Table 76. Caris Life Sciences Company Details
    Table 77. Caris Life Sciences Business Overview
    Table 78. Caris Life Sciences Hereditary Cancer Testing Product
    Table 79. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 80. Caris Life Sciences Recent Developments
    Table 81. BioReference Laboratories (GeneDx) Company Details
    Table 82. BioReference Laboratories (GeneDx) Business Overview
    Table 83. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
    Table 84. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 85. BioReference Laboratories (GeneDx) Recent Developments
    Table 86. LabSolutions Company Details
    Table 87. LabSolutions Business Overview
    Table 88. LabSolutions Hereditary Cancer Testing Product
    Table 89. LabSolutions Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 90. LabSolutions Recent Developments
    Table 91. Progenity，Inc Company Details
    Table 92. Progenity，Inc Business Overview
    Table 93. Progenity，Inc Hereditary Cancer Testing Product
    Table 94. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 95. Progenity，Inc Recent Developments
    Table 96. ARUP Laboratories Company Details
    Table 97. ARUP Laboratories Business Overview
    Table 98. ARUP Laboratories Hereditary Cancer Testing Product
    Table 99. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 100. ARUP Laboratories Recent Developments
    Table 101. Myriad Company Details
    Table 102. Myriad Business Overview
    Table 103. Myriad Hereditary Cancer Testing Product
    Table 104. Myriad Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 105. Myriad Recent Developments
    Table 106. NeoGenomics Company Details
    Table 107. NeoGenomics Business Overview
    Table 108. NeoGenomics Hereditary Cancer Testing Product
    Table 109. NeoGenomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 110. NeoGenomics Recent Developments
    Table 111. Blueprint Genetics Company Details
    Table 112. Blueprint Genetics Business Overview
    Table 113. Blueprint Genetics Hereditary Cancer Testing Product
    Table 114. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 115. Blueprint Genetics Recent Developments
    Table 116. CellMax Life Company Details
    Table 117. CellMax Life Business Overview
    Table 118. CellMax Life Hereditary Cancer Testing Product
    Table 119. CellMax Life Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 120. CellMax Life Recent Developments
    Table 121. Fulgent Genetics Company Details
    Table 122. Fulgent Genetics Business Overview
    Table 123. Fulgent Genetics Hereditary Cancer Testing Product
    Table 124. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 125. Fulgent Genetics Recent Developments
    Table 126. Strand Life Sciences Company Details
    Table 127. Strand Life Sciences Business Overview
    Table 128. Strand Life Sciences Hereditary Cancer Testing Product
    Table 129. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 130. Strand Life Sciences Recent Developments
    Table 131. Myogenes Company Details
    Table 132. Myogenes Business Overview
    Table 133. Myogenes Hereditary Cancer Testing Product
    Table 134. Myogenes Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 135. Myogenes Recent Developments
    Table 136. LabCorp Company Details
    Table 137. LabCorp Business Overview
    Table 138. LabCorp Hereditary Cancer Testing Product
    Table 139. LabCorp Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 140. LabCorp Recent Developments
    Table 141. Quest Diagnostics Company Details
    Table 142. Quest Diagnostics Business Overview
    Table 143. Quest Diagnostics Hereditary Cancer Testing Product
    Table 144. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 145. Quest Diagnostics Recent Developments
    Table 146. Pathway Genomics Company Details
    Table 147. Pathway Genomics Business Overview
    Table 148. Pathway Genomics Hereditary Cancer Testing Product
    Table 149. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2017-2022) & (US$ Million)
    Table 150. Pathway Genomics Recent Developments
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2021 VS 2028
    Figure 2. RNA Testing Features
    Figure 3. DNA Testing Features
    Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2021 VS 2028
    Figure 5. Breast Cancer Case Studies
    Figure 6. Gastrointestinal Cancer Case Studies
    Figure 7. Prostate Cancer Case Studies
    Figure 8. Respiratory/Lung Cancer Case Studies
    Figure 9. Other Cancers Case Studies
    Figure 10. Hereditary Cancer Testing Report Years Considered
    Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Hereditary Cancer Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hereditary Cancer Testing Market Share by Region: 2021 VS 2028
    Figure 14. Global Hereditary Cancer Testing Market Share by Players in 2021
    Figure 15. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Cancer Testing as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2021
    Figure 17. North America Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
    Figure 19. North America Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
    Figure 20. North America Hereditary Cancer Testing Market Size Share by Country (2017-2028)
    Figure 21. United States Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Hereditary Cancer Testing Market Size Share by Country (2017-2028)
    Figure 27. Germany Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Hereditary Cancer Testing Market Size Share by Region (2017-2028)
    Figure 37. China Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Hereditary Cancer Testing Market Size Share by Country (2017-2028)
    Figure 47. Mexico Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Hereditary Cancer Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Hereditary Cancer Testing Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Hereditary Cancer Testing Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Hereditary Cancer Testing Market Size Share by Country (2017-2028)
    Figure 53. Turkey Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Hereditary Cancer Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 57. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 58. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 59. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 60. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 61. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 62. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 63. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 64. Myriad Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 65. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 66. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 67. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 68. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 69. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 70. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 71. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 72. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 73. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
Myriad
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Strand Life Sciences
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Frequently Asked Questions
Hereditary Cancer Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Cancer Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Cancer Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hexachlorodisilane

Hexachlorodisilane market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More